Antibody responses of healthy infants to concurrent administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines

BioDrugs

Volumn 15, Issue 6, 2001, Pages 413-418

  West, D J ^a   Rabalais, G P ^b   Watson, B ^c   Keyserling, H L ^d   Matthews, H ^e   Hesley, T M ^e  

^a University of Louisville ^*

^b University of Louisville School of Medicine   (United States)

^c EINSTEIN MEDICAL CENTER   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TOXIN; HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HEPATITIS B SURFACE ANTIGEN; INACTIVATED VACCINE; M-M-R; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS TOXIN; POLIOMYELITIS VACCINE; RUBELLA ANTIBODY; TETANUS TOXIN; VIRUS ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG TOLERABILITY; ENZYME IMMUNOASSAY; FEMALE; HAEMOPHILUS INFLUENZAE; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0034908151     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200115060-00007     Document Type: Article

References (13)

1. Hepatitis B control through immunization
2. Haemophilus b conjugate vaccines for the prevention of Haemophilus influenzae type b disease among infants and children two months of age and older: Recommendations of the Immunization Practices Advisory Committee (ACIP)
3. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP)
4. Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants
5. Immunogenicity of a new Haemophilus influenza type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB®)
6. Epidemiological standardization of a test for susceptibility to mumps
7. Use of color change of phenol red as the indicator in titrating poliomyelitis virus or its antibody in a tissue-culture system
8. Standardization of poliovirus neutralizing antibody tests
9. Micro cell culture method for determination of diphtheria toxin and antitoxin titers using VERO cells
10. Serological response to Bordetella pertussis
11. The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells
12. Concurrent administration of routine pediatric vaccines with COMVAX™ (Haemophilus b Conjugate [Meningococcal Protein Conjugate] and Hepatitis B [Recombinant] Vaccine)